GSK Egypt posted non-consolidated net profits after tax of EGP 71.33 million in H1-25, an annual drop from EGP 99.54 million. Meanwhile, the EPS declined to EGP 0.85 from EGP 1.19. In April-June 2025, ...

With the stock currently priced at Rs 2,724.90, GlaxoSmithKline Pharmaceuticals shows significant activity in today's session ...

Arab Finance: GlaxoSmithKline Egypt (GSK–Egypt) logged consolidated net profits for controlling interest of EGP 65.060 ...

GlaxoSmithKline has announced the purchase of 306,478 of its own ordinary shares as part of its ongoing buyback programme. This transaction, executed through Merrill Lynch International, is part of a ...

Net Sales at Rs 804.83 crore in June 2025 down 0.76% from Rs. 811.00 crore in June 2024. Quarterly Net Profit at Rs. 204.70 ...

Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, leading to its shares declining the most in nearly four months.

Innovation is the bedrock on which GlaxoSmithKline (GSK) plc is built. Nearly 300 years after the founding of the pharmacy from which the modern firm has evolved, GSK remains committed to exploring ...

How GlaxoSmithKline missed red flags in China By Ben Hirschler July 19, 20136:40 AM PDTUpdated July 19, 2013 ...

GSK plc announced the acquisition of ordinary shares by several key executives under the Company’s Share Reward Plan. This transaction, conducted on the London Stock Exchange, involved the purchase of ...

Less than two months after GlaxoSmithKline pledged to cap out-of-pocket costs for its inhalers at $35 a month, Sen. Maggie Hassan (D-N.H.) is accusing the company of circumventing that vow through ...

GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday (Apr 25), accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies’ ...

(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies ...